Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 00:49 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors
NCT01234922 · Wake Forest University Health Sciences · PHASE2 · terminated · last registry update 2018-08-28 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “slow accrual” | – | Registry record, Wake Forest University Health Sciences |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against ACE within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2019-06-21Also stopped (withdrawn): Charles University, Czech Republic, Atorvastatin, Amlodipine, Perindopril (NCT03047538)
- 2019-05-08Results posted on the registry: Masonic Cancer Center, University of Minnesota, doxorubicin hydrochloride + enalapril maleate (NCT00895414)
- 2019-04-17Phase 3 first posted: Novartis Pharmaceuticals, LCZ696 + Enalapril matching placebo (NCT03917459)
- 2019-04-08Results posted on the registry: Novartis Pharmaceuticals, sacubitril/valsartan (LCZ696) + enalapril (NCT02970669)
- 2019-03-26Also stopped (terminated): Rennes University Hospital, Amlodipine (NCT00151619)
- 2018-10-11Also stopped (withdrawn): Brigham and Women's Hospital, sacubitril/valsartan + Enalapril (NCT03119623)
- 2018-08-27Results posted on the registry: Vanderbilt University, Sitagliptin + Placebo (NCT02639637)
- 2018-01-11Also stopped (withdrawn): Vanderbilt University Medical Center, Valsartan 80 mg bid + Enalapril 10 mg bid (NCT03005184)
- 2017-12-11Results posted on the registry: University of Nebraska, ACEI continuation + ACEI omission (NCT01669434)
- 2017-09-28Results posted on the registry: Duke University, ACE-I Cessation group + ACE-I Continuation group (NCT01867047)
- 2017-09-28Also stopped (terminated): Duke University, ACE-I Cessation group + ACE-I Continuation group (NCT01867047)
- 2017-08-29Phase 3 first posted: South Tees Hospitals NHS Foundation Trust, Enalapril (NCT03265574)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision